Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy
- 作者Warner K Huh; Matthew Powell; Charles A Leath III; J.Michael Straughn Jr.; David E Cohn; Michael A Gold; Camille A Falkner; Delicia E Carey; Thomas Herzog; Jeffrey M Fowler; Edward E Partridge; Larry C Kilgore; Ronald D Alvarez
- 卷第91卷
- 期第3期
- 印刷ISSN0090-8258
- 电子ISSN1095-6859
- 文件大小129.58KB
- 发表时间2003
- DOI10.1016/j.ygyno.2003.08.027
- 页码470-475
Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapyJonathan Markman; Kristine Zanotti; Kenneth Webster; Jerome Belinson; Gertrude Peterson; Barbara Kulp; Maurie Markman · 2004
Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancerMaurie Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Gertrude Peterson; Jerome Belinson · 2003
Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancersMaurie Markman; Jon Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Gertrude Peterson; Jerome Belinson · 2004
Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactionsMaurie Markman; Fred Hsieh; Kristine Zanotti; Kenneth Webster; Gertrude Peterson; Barbara Kulp; Ann Spicel; Jerome Belinson · 2004
Phase 2 trial of carboplatin plus tamoxifen in platinum-resistant ovarian cancer and primary carcinoma of the peritoneumMaurie Markman; Kenneth Webster; Kristine Zanotti; Gertrude Peterson; Barbara Kulp; Jerome Belinson · 2004
Phase 2 trial of prolonged administration of oral topotecan in platinum/taxane-refractory ovarian, fallopian tube, and primary peritoneal cancersMaurie Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Gertrude Peterson; Jerome Belinson · 2004
Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trialsMaurie Markman; Kenneth Webster; Kristine Zanotti; Gertrude Peterson; Barbara Kulp; Jerome Belinson · 2004
Examples of the marked variability in the relationship between the serum CA-125 antigen level and cancer-related symptoms in ovarian cancerMaurie Markman; Kenneth Webster; Kristine Zanotti; Gertrude Peterson; Barbara Kulp; Jerome Belinson · 2004